Relypsa’s Potassium-Lowering Drug Clears FDA, But Dosing Warning Could Impact Use
This article was originally published in The Pink Sheet Daily
Boxed warning says other oral drugs should be taken at least 6 hours before or after; Veltassa to launch in January with support from Sanofi’s sales force.
You may also be interested in...
Biopharmaceuticals President Ruud Dobber talked to Scrip about the launches of Lokelma and roxadustat in kidney disease, building with a high bar in cardiovascular disease and expanding in cell and gene therapy.
Allergan backs out of deal with Adamis for an EpiPen competitor just two months after signing the licensing deal, but before an up-front payment due date kicks in. AbCellera to team with MassBiologics to discover antibodies against drug-resistant Klebsiella infections.
Companies are racing to co-develop coronavirus treatments before finalizing deal teams. These team-ups raise questions about what happens after the pandemic subsides.